| abstract |
The present invention concerns methods for identifying, producing, and engineering nbinding molecule conjugates, and to the conjugates produced. In particular, the invention n5 concerns Surrobody conjugates composed of an antibody heavy chain variable domain and a nsurrogate light chain, wherein the surrogate light chain and/or the antibody heavy chain nvariable domain is conjugated to a therapeutic or diagnostic agent. n9645400_1 (GHMatters) P97558.AU.1 |